Dimmock J R, Erciyas E, Raghavan S K, Kirkpatrick D L
College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.
Pharmazie. 1990 Oct;45(10):755-7.
1-Phenyl-3-(4-morpholinyl)propan-1-one hydrochloride 1 and the related piperidino derivative 2 were shown to have activity against the EMT6 tumour in vitro. Modification of the structures of these compounds by introducing a glucosyloxy group onto the aryl rings lowered cytotoxicity but conversion of 1 and 2 into the corresponding bis-Mannich bases increased bioactivity considerably.